A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionSerotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major DepressionA Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionAuricular Concha Electro-acupuncture for the Treatment of DepressionTranscranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY StudySerotonin and Motor PlasticityDepression in Older AdultsTime to Remission of Depressive Symptoms With Combined SSRI and RamelteonEscitalopram Treatment of Night Eating SyndromeEscitalopram and Depression in Elderly Alzheimer's PatientsFlushing in Social Anxiety Disorder on CipralexSerotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant ResponsePre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant TreatmentAcamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and AlcoholismGalantamine Augmentation of Escitalopram for Treatment of DepressionA Study for Participants With Major DepressionEscitalopram in Depressive Patients With Acute Coronary Artery SyndromeAn Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety DisorderPACEPro - Mood Management PilotSTAR*D Alcohol: Treatment of Depression Concurrent With Alcohol AbuseEfficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.Imaging Predictors of Treatment Response in DepressionCitalopram in Treating Postmenopausal Women With Hot FlashesAripiprazole and Lexapro Drug Interaction StudySelective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality DisorderNeural Responses and Dysphoria: Modulation by a Pharmacological ProbeAntidepressants to Promote Recovery of Cardiac Patients Suffering From DepressionSafety and Efficacy of Vilazodone in Major Depressive DisorderMagnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive DisorderNeuroimaging Predictors of Antidepressant Treatment OutcomeElectrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive DisorderBioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed ConditionBioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting ConditionAntidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsPreventing Depression in People Receiving Mechanical Ventilation in an Intensive Care UnitA Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in DepressionA Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting ConditionsA Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting ConditionsA Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed ConditionsAntidepressants Trial in Parkinson's Disease
P4844
Q61862274-4B9A5F84-09C0-4652-B619-3227293A35BDQ61894254-E80589EA-74DF-41C8-8782-DD677F814C1FQ61902365-2D6AF137-9C36-47F0-8F00-6141D7B5119FQ61907141-0578DE98-9422-495C-A568-8838AA78B2EBQ61907182-5C2EB64B-7264-45AA-8048-AF9CB8D9D675Q61909124-F8ECDB55-B256-47C3-BB1A-759BE1616F7DQ61914655-8F22BCF1-4811-4717-9AB6-6FD7D6CB63FCQ61914702-94870710-9688-47A8-BAF8-1069AEDF0ED0Q61915306-4AFE8615-4229-4136-86B9-C14BE2F6213AQ61918216-56F80BE0-5CDC-4F14-ADFF-AAD2DAD82BC7Q61918473-81DB82D1-9A57-406C-8570-A9D112B9517EQ61920551-A3ED209C-A5E9-4289-88EC-694093C10A3DQ61920584-7021BB80-7E54-41F8-9C5D-602D3EB1E231Q61920866-702C5C54-B3C2-4AB7-99F1-F6DFC8AC0EE2Q61921641-DA2DEC2A-FF8C-4153-88CE-411723EAE00CQ61922015-E2396236-15EC-40C2-BA95-A749B623D710Q61922069-10C229C5-837B-40AA-AF60-F2CAA04C7EEDQ61922321-F1D3741D-EA90-4772-A4FC-91974F2976CFQ61922426-DBD96D08-225E-4FD0-8A1F-937D3C3727FFQ61933477-DCF7A346-7B4C-4C1F-B179-E747017828FBQ61933645-4817A0A8-1FE8-406E-8E61-4FE17C6E6D47Q61933918-B04E02A3-C4AF-4205-A549-67B5ADE1E460Q61934602-5AE0235F-80DC-46B9-8B24-219724A502C3Q61934938-15A25A20-BD92-41BE-99B9-AA12BEF57C97Q61935821-526D4AD5-72DF-4488-BA38-56EDD1A389E6Q61935989-62C12265-2E02-428B-A291-44722D9C2C10Q61936195-EA101CF3-C167-4FDF-9581-9716D449B614Q61955353-84DD6265-9F99-43EA-AEB5-9C337AEBABB2Q61965722-F130EF67-5B59-4AD3-8C77-AB0252DD9DBDQ61969268-C17D73DE-8FDF-45E1-998E-42653418C247Q61969514-E508F85F-64F8-4C5A-8215-A5AA7445ECFBQ61969603-4EB6A933-8A71-4BB7-B5EA-7AEB097F2F9BQ61969604-79728506-74F1-41E0-9420-99893D5DBDDCQ61975132-09182C62-89C9-4692-A5E1-1B749CA57982Q61980515-8E1B0CAD-FFBB-4E1B-9F4A-8650C0590254Q61980977-8FA4F4DC-98CA-44ED-A552-A820CCCA4AFFQ61981027-9DE0615A-0C3B-45DA-A1EC-402FF72324B7Q61981103-94A94091-D69A-4389-8811-728850194212Q61981120-C931BE13-BC91-4733-96B4-20A63A4BBE99Q62025216-624DFF9F-040A-450B-8D83-AD09BDC93E0F
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Deksetimid
@sh
Deksetimid
@sr
Dexetimid
@hu
Dexetimide
@vi
dexetimide
@en
Дексетимид
@ru
دکستیمید
@fa
type
label
Deksetimid
@sh
Deksetimid
@sr
Dexetimid
@hu
Dexetimide
@vi
dexetimide
@en
Дексетимид
@ru
دکستیمید
@fa
altLabel
(+)-benzetimide
@en
Dexetimide
@en
R 16470
@en
Tremblex®
@en
prefLabel
Deksetimid
@sh
Deksetimid
@sr
Dexetimid
@hu
Dexetimide
@vi
dexetimide
@en
Дексетимид
@ru
دکستیمید
@fa
P2868
P486
P592
P6366
P646
P661
P662
P665
P683
P2017
C1CN(CCC1[C@@]2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4
P2067
362.199428
P2275
Dexetimide
@en
P231
21888-98-2
P233
C1CN(CCC1C2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4
P234
1S/C23H26N2O2/c26-21-11-14-23( ...... 1-17H2,(H,24,26,27)/t23-/m1/s1
P235
LQQIVYSCPWCSSD-HSZRJFAPSA-N
P267
P274
C₂₃H₂₆N₂O₂